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Over the past decade there have been numerous descriptions of suppressor T 
cells (Ts) and of factors derived from such cells. Several apparently related, but 
nonidentical,  suppressor  regulatory  pathways  consisting  of a  variety  of T-T 
interactions have been described (1-4). Our laboratory has concentrated on one 
of these models of antigen-specific suppression involving the hapten  4-hydroxy- 
3-nitrophenyl acetyl (NP).  In the  NP model system, we have identified at least 
three distinct suppressor T  cell subsets (Tsl,  Ts2, Tss) (5-7).  Furthermore,  we 
have  demonstrated  a  requirement  for accessory cells at  various points  in  the 
suppressor pathway (8, 9). All of these cellular elements are needed to modulate 
the  contact  sensitivity  (CS)  response  to  NP.  Furthermore,  the  same  T  cell 
populations are required for suppression of NP-specific plaque-forming cell (PFC) 
responses (10,  1 1). 
The final effector T  cell population in the suppressor cell cascade appears to 
be an  Lyt-2  + subset  that  we  have  termed  Ts~  (6).  Ts3  cells are  induced  as  a 
consequence of conventional immunization concomitant with the induction of T 
cells mediating  helper or CS activity (8,  12).  However, these primed  Ts~  cells 
appear to remain  inactive until appropriately triggered by Ts2 cells or a  factor 
derived from Ts9 cells (12,  13).  The  Ts3 cells are antigen-specific and bind to 
NP-coated petri dishes (6, 7,  14). They react with anti-Thy-1, anti-Lyt-2, anti-I- 
J, and anti-NP b (antiidiotype) antisera (6, 7,  14).  The activity of Ts3 cells can be 
demonstrated in cyclophosphamide-treated recipients and is restricted by I-J and 
Igh genes (6,  12). 
Ts~ hybridomas that constitutively secrete a suppressor factor, TsFs, have been 
obtained in the NP system. Five hybridoma T  cell lines were prepared by fusion 
of C57BL/6 (B6) or CKB derived Ts~ cells with the BW5147 thymoma (7). The 
supernatants  from these Ts3 cell hybridomas contain factors (TsF~) which,  like 
Ts~ cells have the capacity to specifically suppress NP-induced CS responses (7). 
* Abbreviations used in this paper: B6, C57BL/6 mice; CS, contact sensitivity; CY, cyclophosphamide; 
60  $0  I0  DMSO, dimethylsulfoxide; DNFB, 2.4-dinitroflorobenzene; GAT, po]y-(L-glu , L-ala  , L-tyr ); 
KLH, keyhole limpet hemocyanin; NP, 4-hydroxy-3-nitrophenyl  acetyl hapten; NP-O-Su, NP-succi- 
nimide ester; PBS, phosphate-buffered saline; PFC, plaque-forming cell; RAMG, rabbit anti-mouse 
immunoglobulin; Ts~, Ts~, Tss first-, second, and third-order suppressor T cells; TsF~, YsF2, TsFs, 
suppressor factors derived from TSh Ts~, and Tsn cells. 
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Suppression of CS responses is only observed if TsF3 is administered during the 
effector phase of the  immune  response.  TsF3 reacts with allele-specific anti-I-J 
and anti-NP b antisera and has binding specificity for the NP hapten (7). Further- 
more,  TsF3  does not  suppress  I-J  incompatible  mice.  In  addition  to  this  H-2 
restriction, the monoclonal TsF3 factors also demonstrate Igh genetic restrictions. 
Thus,  TsF3 displays dual genetic restrictions  for both I-J and  Igh linked genes 
(7). 
Taniguchi  et  al.  (15,  16)  have  shown  that  a  KLH-specific TsF3-1ike  factor 
consists of a  molecular dimer composed of a  I-J-related piece (28,000  daltons) 
and  an  antigen-binding  piece  that  bears  determinants  encoded by Igh-linked 
genes.  The  latter piece may have a  membrane  (45,000  daltons) and secretory 
(35,000  daltons) form  (15).  We have performed similar  studies to analyze the 
molecular organization of the NP-specific TsFs (17). Thus, NP-specific TsFs was 
reduced  and  passed  over antigen  or anti-I-J  immunoadsorbent  columns.  The 
activity of the  reduced  TsF3  could  not  be recovered in  the  eluate  or  filtrate 
fractions from either column. However, suppressor activity was reconstituted by 
combining the appropriate  filtrate  and  eluate  fractions  (17).  These results are 
similar  to those described  by Taniguchi  et al.  for  KLH-specific TsF  (15,  16). 
The data imply a two-chain disulfide-linked structure for TsF3, one chain binds 
antigen and the other bears I-J-related determinants.  To determine if the same 
class of TsF3 molecules were responsible for suppression of PFC responses, some 
of these fractions were also tested for suppressive activity in vitro, using NP-ficoll 
cultures  (11).  The  data demonstrated  that  hybridoma-derived TsF3  molecules 
with similar biophysical characteristics were responsible for suppression of both 
CS and PFC responses (11,  17). 
Since TsF~ is dual restricted and consists of a two-chain structure, we consid- 
ered  the  possibility that  each  chain  controlled  one  of the  genetic  restrictions. 
Efforts  to  physically  separate  and  reassociate  the  chains  from  different  TsF 
sources have failed in another system (18). Therefore, we used another approach 
to analyze this issue. The genetic restrictions of Ts3 cells from NP-primed H-2 
and Igh heterozygous (B6 × C3H)F~ mice were analyzed. Four cloned Fl-derived 
Ts3 hybridoma  lines  were established.  The  properties  of these clones are  the 
subject of the present report. 
Materials and Methods 
Mice.  All mice were either purchased from The Jackson Laboratory, Bar Harbor, ME 
or bred in the animal facilities at Harvard Medical School, Boston, MA. Mice were used 
at 2-5 mo of age and  were maintained on laboratory chow and acidified,  chlorinated 
water ad lib. 
Animals used in the study were maintained in accordance with the guidelines  of the 
Committee  on  Animals  of the  Harvard  Medical  School  and  those  prepared  by the 
Committee on Care and Use of Laboratory Animals of the Institute of Laboratory Animal 
Resources, National  Research Council (DHEW publication  No. (NIH) 78-23). 
Antigen.  NP-O-Succinimide  (NP-O-Su)  was purchased from the Biosearch  Co.,  San 
Rafael, CA, Dimethylsulfoxide  (DMSO) was purchased from Fisher Scientific Co., Pitts- 
burgh, PA. 2,4-dinitro-l-fluorobenzene (DNFB) was obtained from Eastman  Kodak Co., 
Rochester, NY. 
Antisera.  Both  B10.A(3R) anti-B10.A(5R)  (anti-I-J  k)  and  B10.A(SR)  anti-B10.(3R) 
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elsewhere (19).  Monoclonal anti-I-J antibodies, WF8.C2.4 (anti-I-jk), WF8.D2.3 (ant-I-jk), 
and WF9.40.5 (anti-I-J b) were characterized previously (20,  21).  Both monoclonal anti- 
Thy-l.1  and  Thy-l.2 antibodies were purchased from New England Nuclear,  Boston, 
MA.  Guinea pig anti-CGAT, anti-NP  b and anti-NPJ  antiidiotype antisera were prepared 
as  detailed  elsewhere  (19).  These  reagents  detect  a  common  idiotype  on  anti-GAT, 
C57BL/6 anti-NP, and C3H anti-NP antibodies, respectively, and have been described 
previously (22, 23). 
In Vitro Activation of NP-primed  Lymph Node  Ts3 Cells with TsF2.  Regional lymph node 
cells from mice that had been immunized subcutaneously with 2 mg NP-O-Su were used 
as the source of Tsa cells (12). B6-Ys2-28, C3H.SW-Ts2-7, and CKB-Ts~-59-derived TsF2, 
which have been previously characterized and described (12, 24), were used for activation 
of lymph node Ts3 cells in vitro. 5 X 107 NP-primed lymph node cells were cultured for 
2 h in  10 ml RMPI 1640 with  10% fetal calf serum and 0.1  mM Hepes plus 50 #1 TsF2 
ascites fluid derived from B6-Ts2-28,  CKB-Ts~-59 C3H.SW-Ts2-7, or BW5147 cells that 
were  grown in  (AKR x  B6)F1, (AKR X CKB)FI,(AKR ×  C3H.SW)FI, or AKR mice, 
respectively. After culture, these activated lymph node cells were washed three times with 
Hanks' balanced salt solution and resuspended. 
Functional Analysis of the Activated NP-primed  Lymph Node Ts3 Cells in Cyclophosphamide- 
treated Antigen-primed Mice.  Mice were primed subcutaneously with 2 mg of NP-O-Su in 
DMSO  on  day  0,  as  described  elsewhere  (12).  24  h  later,  they were  treated  with  an 
intraperitoneal injection of 20 mg/kg_ cyclophosphamide (CY) in saline.  On day 6, each 
mouse received intravenously 1 x  10' NP-primed lymph node cells activated with TsF2 
or control BW5147 factors, as described above, or received 0.5 ml of TsF~ or control 
BW5147 factors. Immediately after transfer,  mice were challenged for CS responses. It 
should be  noted that  1 x  107  immune lymph node cells are  not sufficient to transfer 
immunity under these experimental conditions. 
Preparation  of Ts3  Cells from  Antigen  Plates.  The  methods  for the  preparation  and 
enrichment of NP-binding T  cells were described in detail elsewhere (7,  14). In brief, 5 
x  107 regional lymph node cells from (C57BL/6 ×  C3H)F~ mice that were immunized 
subcutaneously with 2 mg NP-O-Su were added to purified anti-mouse immunogiobulin 
(RAMG)-coated petri dishes  to remove B cells. The nonadherent T  cells were incubated 
on  NP-bovine  serum  albumin-coated  petri  dishes  for  45  min  at  room  temperature. 
Nonadherent cells were removed by gentle swirling,  and the plates were placed on ice for 
20 min. The antigen-binding cells were collected from the plate by gentle pipetting and 
used as the source of Tsa cells. 
Hybridization and Screening of Ts~ Hybridoma Lines.  Ts3-enriched (C57BL/6 ×  C3H)F1 
lymphocytes were hybridized with BW5147 T  lymphoma cells. The polyethylene glycol- 
mediated hybridizing method was exactly the same as previously reported (7,  19). The 
hybridized Ts~ candidates were screened using a cytotoxicity test (19) with allele-specific 
anti-I-J reagents. Two fusions were performed and ~500 colonies were screened. 
All of the hybridomas were cultured in RMPI 1640 containing 8% fetal calf serum and 
0.01  M  Hepes  buffer.  The  suppressor  factors  used  in  the  present  experiment  were 
collected from the cultured supernatants of cells at an approximate density of 7  ×  105 
cells/mi in the above medium. 
Adsorption  and Elution  of TsF.  The method of absorption and elution  of TsF using 
protein-conjugated Sepharose-4B columns were described in detail previously (25). 
Assay for Suppressive Activity of TsF on NP-mediated  Cutaneous or Contact Sensitivity (CS) 
Responses.  The assay for NP-specific  CS responses was described elsewhere (26). Briefly, 
each animal was primed subcutaneously with  1 or 2 mg of NP-O-Su in DMSO.  Unless 
indicated otherwise, the hybridoma factors were tested in the effector phase, 5 and/or 6 
d after priming. 0.4 ml of each hybridoma supernatant or BW5147 control supernatant 
was injected i.v. on the day before and the day of antigen challenge (6 d after immuniza- 
tion).  Mice were challenged in the left footpad with 0.025 ml phosphate-buffered saline 
(PBS) solution containing 30 #g of NP-O-Su (prepared by mixing 25 ~tl of a  2%  NP-O- 
Su/DMSO solution in 0.4 ml PBS). Footpad swelling was measured 24 h after challenge. 
Swelling was determined as the difference in units of 10  -a cm between the left and right MINAMI  ET  AL.  1431 
footpad thickness. 
DNFB Contact Sensitivity  Responses.  Contact sensitivity was induced by two daily paint- 
ings on the shaved abdomen with 25 #1 of 0.5% DNFB solution  in acetone olive oil (4:1) 
(25). 6 d after the last painting 20 #i of 0.2%  DNFB in the same vehicle was applied to 
the left ear and the ear swelling was measured as the difference between the left and right 
ear thickness. 
Percent Suppression.  The percent suppression  in the present study was calculated  by 
the following formula:  percent suppression  -- 100 × [(swelling of BW5147 tumor super- 
natant  injected group -  swelling of TsF injected group)/(swelling of BW5147 tumor 
supernatant injected group -  swelling of unprimed group)]. 
Data  Analysis.  Statistical  analysis of experimental  data with  respect to controls was 
calculated using two-tailed Student's t test. 
Results 
Our initial  experiments were designed to analyze the specificity of Ts3 popu- 
lations derived from H-2 and Igh heterozygous (B6 × C3H)F~ mice. One purpose 
of these studies was to determine whether we could identify Tsa populations in 
which the H-2 restriction  specificity was derived from one parent and  the Igh 
restriction specificity was derived from the other parent. Ts3 cells were generated 
in (B6 X C3H)F1 donors (H-2b; Ighb/H-2k; Igh  j) by s.c. priming with 2 mg NP- 
O-Su. After 6 d,  1 x  107 draining  lymph node cells that  had been activated in 
vitro with monoclonal TsF~ from a variety of sources were adoptively transferred 
to NP-primed cyclophosphamide (CY)-treated C57BL/6 (H-2b; Ighb), C3H.SW 
(H-2b;  IghJ),  C3H  (H-2k;  IghJ),  CKB (H-2k;  Ighb),  or (B6 X  C3H)F~  recipients. 
The  CY treatment  functionally eliminates  Ts~  generation  in  the  recipients,  as 
evidenced by the inability of TsF~ to suppress CS responses in CY-treated animals 
(Table I).  This  reconstitution  protocol allows direct analysis of Ts~  activity by 
the adoptively transferred  cell population.  The recipients  were challenged  im- 
mediately after cell transfer. Footpad swelling was measured 24 h after challenge. 
The data  in  Table  I  summarize  the results of seven experiments  using this  in 
vivo system.  (B6  ×  C3H)F~  Ts3  cells  that  were transferred  to  CY-treated  B6 
recipients,  were only activated following coculture with  B6-derived TsF2,  sup- 
pression was not observed following activation  with CKB, or C3H.SW-derived 
TsF2  in  these  recipients.  When  the  same  Ts3  cell  population  was adoptively 
transferred  to  C3H.SW  recipients,  only  the  C3H.SW-derived  TsF2  activated 
these cells to mediate  their  suppressive activity. The  TsF2 derived from  H-2- 
compatible Igh-incompatible B6 donors, was functionally unable to activate (B6 
×  C3H)FI  Ts3  cells  when  assayed  in  C3H.SW  recipients,  although  as  shown 
above the  same Fl-derived  Ts~  population  was functional  when assayed in  B6 
recipients. Similarly, only CKB-derived TsF2 was capable of activating the (B6 × 
C3H)F~-derived Ts5 population to express functional suppressive activity in CKB 
or  B10.BR  recipients.  TsF2  derived  from  H-2-incompatible  B6  donors  was 
unable to activate the (B6 ×  C3H)F~ Ts3 subpopulation to mediate suppression 
in  CKB  or  B10.BR  recipients.  Furthermore,  neither  B6,  C3H.SW,  or  CKB- 
derived YsF2 could activate (B6 ×  C3H)F~ Ts3 cells that were adoptively trans- 
ferred to C3H recipients.  Unfortunately,  we have not prepared  a  monocional 
C3H-derived TsF2 to serve as positive control for the latter groups. Nonetheless, 
it appears that the (B6 ×  C3H)F~ Ts3 population,  consists of at least three and 
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TABLE  I 
Activation of H-2 and Igh Heterozygous Tss Cells with Monoelonal Suppressor Factors* 
TsF2 source for Tss  Footpad swelling + SE  e  CY-treated recipient  Tss donor  activation 
C57BL/6  (B6 x C3H)F~  BW5147  35.5 + 2.2 (17) 
(B6 x C3H)F~  B6-Ts2-28  19.1 + 2.0 (17)* 
(B6 x  C3H)F~  C3H.SW-Ts2-7  33.7 :t: 1.3 (16) 
(B6 x C3H)FI  CKB-Tsr59  34.5 ± 2.4 (4) 
None  BW5147  33.8 ±  1.9 (9) 
None  B6-Ts2-28  32.9 ± 2.8 (7) 
C3H.SW  (B6 x  C3H)F~  BW5147  32.8 ±  1.4 (23) 
(B6 x C3H)F~  B6-Ts~-28  33.8 ± 2.3 (20) 
(B6 x C3H)F,  C3H.SW-Tsr7  19.9 ±  1.5 (20)* 
(B6 x C3H)F~  CKB-Ts2-59  33.8 ± 2.1 (4) 
None  BW5147  34.9 ± 2.9 (9) 
None  C3W.SW-Tsr7  30.9 ± 2.5 (8) 
C3H  (B6 x C3H)F,  BW5147  36.2 + 2.8 (12) 
(B6 x C3H)F~  B6-Tsr28  35.4 ± 2.7 (11) 
(B6 X C3H)F~  C3H.SW-Ts2-7  34.2 ± 2.2 (13) 
(B6 x C3H)E~  CKB-Ts2-59  33.9 ± 3.6 (8) 
CKB or B10.BR  (B6 x C3H)Ft  BW5147  37.4 ± 2.2 (8) 
(B6 x C3H)F~  B6-Tsr28  37.8 ±  1.9 (9) 
(B6 x  C3H)F~  C3H.SW-Ts2-7  38.1 ± 2.1 (8) 
(B6 x C3H)F~  CKB-Ts2-59  24.2 ±  1.8 (9)* 
None  BW5147  39.5 ± 4.2 (4) 
None  CKB-Tsr59  36.0 ± 2.3 (4) 
(B6 x C3H)FI  (B6 x C3H)F~  BW5147  32.0 ±  1.8 (4) 
(B6 x  C3H)FI  B6-Tsr28  18.5 ±  1.3 (4)* 
(B6 x C3H)F~  C3H.SW-Tsr7  22.7 ± 2.3 (3)* 
(B6 x C3H)Fj  CKB-Tsr59  18.3 ±  1.7 (4)* 
None  BW5147  30.0 ±  1.6 (5) 
None  B6-Ts~-28  32.3 ± 2.6 (4) 
* In vitro activation of regional lymph node Tss cells from NP-O-Su-primed mice with TsF2 was done 
as described in  Materials and Methods. Activation was continued for 2 h.  Recipient mice were 
primed with NP-O-Su; 24 h later all mice were given 20 mg/kg cyclophosphamide, and 6 d later 
received 1 x  l0  T activated Tss before antigen challenge. The data represent the pooled results 
from seven separate experiments (not all groups were included in each experiment). 
0 The data from seven experiments were pooled and expressed as the increment of footpad swelling 
-  SE in units of 10 -s cm. The background responses of nonimmunized mice ranged from 4.5 to 
13.7.  The  number of mice tested is indicated in  parentheses.  An asterisk indicates significant 
suppression, P<0.01. 
parental  H-2  and  Igh  specificity.  Furthermore,  the  data  suggest  that  each  Ts3 
subpopulation must be activated by a  TsF2, which must share the same H-2 and 
Igh restriction as the Tsa population. Finally, we noted that when (B6 x  C3H)Fl 
recipients  were  used,  either  TsF2  could  activate  the  Tss  subsets  to  express 
suppressive activity (Table I). 
The  present data extend previous results in this system by demonstrating  that 
Tss  cells  derived  from  H-2  and  Igh  heterozygous  F1  mice  can  contain  four 
distinct populations of Tsa  cells, each  restricted to a  particular combination  of 
H-2 and Igh controlled specificities. However, to formally confirm these conclu- 
sions, which are based on analysis of heterogeneous  cell populations, we under- 
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specific Tss cells from (B6 x  C3H)FI  mice were used for the preparation of a 
series of F~-derived Ts3 hybridomas. 
Screening of Hybridoma Suppressor Cells 
Ts3 Suppressor cells were induced by priming (B6 x  C3H)F1 mice with 2 mg 
NP-O-Su s.c.  Tsa cells were purified from regional lymph nodes by successive 
passage over RAMG- and NP-BSA-coated plates. The NP-BSA-adherent T  cells 
were fused with  the  AKR-derived BW5147  thymoma line  with  polyethylene 
glycol; selection of hybridomas seeded at a concentration of 104 lymph node T 
cells per well was carried out with hypoxanthine-aminopterin-thymidine  selective 
media. Hybridoma colonies were noted in ,--~50% of the wells seeded. When the 
colonies were large enough for passage,  an aliquot of cells was tested for the 
presence of I-J alloantigenic determinants by microcytotoxicity testing. 23%  of 
the colonies tested demonstrated at  least +  reactions with at least one allele- 
specific anti-I-J alloantiserum. Supernatants from these colonies were screened 
for in vivo suppression of NP-specific CS responses. 0.5 ml of supernatant fluid 
was given i.v.  on  the day before, and the day of, antigen challenge to (B6  x 
C3H)FI  mice.  Four cell lines that  manifested significant levels of suppression 
were saved for further analysis. 
The four hybridoma cell lines that produced suppressor factors were examined 
for other cell surface markers by microcytotoxicity testing (data not shown). All 
functional (B6 X C3H)F1 hybridoma cell lines were lysed with anti-I-J  b and anti- 
I-J k alloantisera. However, as noted with other Ts hybridoma cell lines (27), the 
percentage of lysis was usually weak (<40%) and with continued in vitro culture 
the ability to lyse these cells was lost or became highly variable.  Antiidiotypic 
reagents  (anti-NP  b)  prepared  against  purified  C57BL/6  anti-NP  or  anti-NIP 
serum antibodies were specifically lytic for the (B6 x  C3H)F1-Ts3-1032 and (B6 
×  C3H)F~-Ts~-I 114 hybridoma cells, but were not lytic for the (B6 X C3H)Fa- 
Ts~-l127  and (B6  ×  C3H)F~-Ts3-1131  lines.  In contrast,  the antiidiotypic re- 
agents (anti-NPj) prepared against purified C3H  anti-NP antibodies were lyric 
for (B6  X C3H)F~-Ts3-1131,  but not for the other three cell lines. Again, the 
percentage of hybridoma cells lysed was generally low (<30%) and after pro- 
longed in  vitro culture the cells were no longer susceptible to lysis with these 
reagents.  In  contrast,  all  these (B6  ×  C3H)Fl-derived  hybridoma lines  were 
readily lysed with either anti-Thy-1.1, anti-Thy-1.2, or anti-H-2D  b antisera all of 
which yielded >80% lysis even after prolonged in vitro culture (data not shown). 
Specificity of Suppressor Factors 
To test the biological activity of these four (B6 x  C3H)F~ hybridoma-derived 
suppressor factors, we screened for the ability of culture supernatants obtained 
from cells growing at a density of ,~7 x  105 cells/ml to suppress in vivo NP or 
DNFB  CS  responses.  Table  II  shows that  i.v.  injection  of 0.5  ml  of culture 
supernatant from the (B6 x  C3H)F1-Ts3-1032,  (B6 x  C3H)F1-Tss-1114,  (B6 x 
C3H)FI-Ts3-1127, and (B6 X C3H)F~-Ts3-1131  cell lines specifically suppressed 
the  NP-induced CS  response  in  (B6  x  C3H)F1  mice.  In  this  experiment the 
percent suppression ranged from 60  to  75%.  In contrast, these culture super- 
natants could not suppress DNFB-induced CS responses. Furthermore, the data 
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TABLE  II 
Antigen Specificity of(B6 × C3H)F1-Ts3 Hybridoma Suppressor 
Factors  ~; 
NP-O-Su foot- 
Recipient strain  Source of TsF  pad swelling +  DNFB ear 
SE a  -  swelling± SE~ 
(B6 × C3H)F~  BW5147  30.0 ± 2.4  12.3 ±  1.5 
F1-Ts3-1032  16.3 + 0.9*  12.3 ± 0.9 
F1-Tss-1114  14.0___2.4"  13.8±1.8 
F1-Tss-1131  14.0 ± 0.6*  13.3 ± 0.9 
F1-Tss-1127  15.0±0.6"  13.5± 1.6 
* Groups of four to five (B6 × C3H)FI mice were immunized with both 
NP-O-Su and DNFB. On the day before and the day of antigen challenge, 
mice were given 0.5 ml of control BW5147 or (B6 × C3H)Fl hybridoma 
derived TsFs, i.v. 
0The background responses  of nonimmunized mice  following antigen 
challenge  were  7.8 ±  1.1  and 3.5 ___ 0.3  ×  10  -3 cm for NP-O-Su and 
DNFB,  respectively.  An  asterisk  indicates  significant  suppression, 
P<0.01, compared with recipients which received control BW5147 fac- 
tor. 
TABLE  III 
Comparison of the Ability of TsF to Suppress CS Responses in the 
Induction vs. Effector Phase* 
Strain of mice 
(B6 x C3H)FI 
Source of TsF 
Time of TsF administration 
Induction phase  Effector phase 
BW5147  35.0 ± 0.3~  43.2 _+ 2.6 
CKB-TsI-17  12.5 _  t.6"  ND 
Fl-TS3-1032  35.0 ___ 1.7  21.8 ± 3.1" 
Fi-Tsa-1114  35.0 -4- 1.3  26.8 _  2.5* 
Fi-Ts3-1127  36.0 ±  1.1  22.8 _+ 2.0* 
Fi-Ts3-1131  34.0 ± 2.0  27.5 ± 0.9* 
* Groups of four to five (B6 × C3H)F~ mice were immunized with NP-O- 
Su and were given TsF either at the time of antigen priming (induction 
phase) or antigen challenge (effector phase). 
Footpad swelling responses _  SE are indicated in units of 10  -3 cm. The 
level of background swelling in unprimed mice that had received  the 
challenge was 10.3 +  1.2. An asterisk indicates significant suppression, 
P<0.01, compared  to groups  which received control BW5147-derived 
factor. 
ND, not determined. 
of the immune response. Thus, when 0.5 ml of factor was injected i.v. either on 
the day of and the day after antigen priming (induction phase) or the day before 
and the day of antigen challenge (effector phase), all the Fi-derived factors only 
functioned in the effector phase.  In confirmation of our previous data (25), the 
control  CKB-Tsl-17  inducer  factor  (TsF1)  demonstrated  suppressive  activity 
when administered during the induction phase (Table III). 
Genetic Restriction  of(B6  ×  C3H)F1-Ts3 derived Factors 
We  had  previously demonstrated that  B6-  or  CKB-derived Ts3  hybridoma 
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Furthermore,  the  previous  data  (Table  I)  indicated  that  at  least  three  and 
probably four distinct populations of Ts3 cells restricted by either parental H-2 
and Igh haplotype exist in H-2 and Igh heterozygous F~ animals. However, in 
the latter experiments heterogeneous populations of T  cells were used and the 
cells were tested in semi-aliogeneic combinations in which allogeneic effects are 
difficult to exclude. Therefore, the production of monoclonal Ts3 hybridomas 
from H-2 and Igh heterozygous FI mice permitted a more definitive analysis of 
the specificity of Frderived Ts3 cells and their factors.  TsF3 was administered 
i.v. during the effector phase of the NP-O-Su-induced CS response. Each F1- 
derived TsF3 was tested in (B6 ×  C3H)Ft, C57BL/6 (H-2b; Ighb), B10.BR (H- 
2k; Ighb), C3H/HeJ (H-2k; IghJ), and C3H.SW (H-2b; IghJ) recipients. As shown 
in Table IV each of the monoclonal (B6  ×  C3H)Fl-derived TsF3  factors are 
restricted to one parental  H-2 and one parental  Igh haplotype.  Thus,  (B6  x 
C3H)F~-Tss-1032  and (B6 × C3H)F1-Tss-1114 factors only suppress NP-induced 
CS responses of C57BL/6 (H-2  b, Igh  b) mice. These factors fail to suppress NP- 
induced CS responses in Igh disparate C3H.SW (H-2  b, Igh  j) recipients or H-2 
congenic B10.BR  (H-2  k,  Igh  b) mice. Similarly, (B6  ×  C3H)F1  Ts-l127  factor 
only suppressed NP-responses of C3H.SW (H-2  b, Igh  j) mice and (B6 × C3H)F1- 
Ts3-1131  factor only suppressed  NP-CS  responses  of C3H  (H-2  k,  Igh  j)  mice 
(Table IV). 
To determine which subregions of the H-2 complex restricted the activity of 
these factors, one hybridoma (B6 x  C3H)F1-Tss-1032  was selected for further 
TABLE  IV 
Genetic Restrictions of(B6 X C3H)FI Hybridoma-derived TsF3 Factors* 
TsFs source 
Normalized Percent Suppression in Various Recipient Strains ± SE  ! 
(B6 x C3H)Fj  C57BL/6  BI0.BR  C3H  C3H.SW 
(H-2b/H-2  ~, 
lghb/lgl9  )  (H-21'; lgh  I')  (H-2k; Igh  b)  (H-2k; Igh  j)  (H-2b; IghJ) 
BW5147  0±4(21)  0:t:2  (21)  0±4  (14)  0+4(17)  0±4  (20) 
(B6×C3H)FrTss-1032  52±6(8)*  67±5  (12)*  22±12(11)  11±6(7)  -1±5  (8) 
(B6×C3H)FrTsrlII4  48±6(15)*  43±8  (16)*  9±6  (13)  6±5(11)  15±10(12) 
(B6×C3H)FrTss-II27  45_+3(15)*  -14±10(8)  13±7  (8)  10±4(13)  88±5  (16)* 
(B6×C3H)FrTss-II31  47±3(15)*  -5-+7  (12)  8±5  (12)  68±5(16)*  6±11(16) 
:i: Groups of mice were immunized with N P-O-Su and were given TsFs on the day before and the day of antigen challenge. 
I The data represent the pooled results from three separate experiments. The data were normalized and the percent suppression ± 
SE was calculated. The number of mice tested is indicated in parentheses. An asterisk indicates significant levels  of suppression, 
P<0.01. 
TABLE  V 
Intra H-2 Mapping of(B6 X C3H)FrTss-1032 Derived Factor* 
Normalized percent suppression __. SE  0 
Source of TsF  C57BL/6  B.C.-8  B10.A(3R)  B10.A(5R) 
(H-2b;  Igh  b)  (H-2b; Igh")  (IJb; Igh  b)  (Ijk; Igh  b) 
BW5147  0 ±  6  0 -+ 5  0 +  7  0 +  5 
F1-Tss-1032  73 ±  7*  -2 ±  7  70 +  7*  3 ±  10 
* Groups of 4-8 mice were immunized with NP-O-Su and were given TsF 
on the day before and the day of antigen challenge. 
The  data  represent  the  normalized  percent  suppression  of _  SE.  An 
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analysis. TsFs derived from this hybridoma was tested in C57BL/6 (H-2  b, Ighb), 
B.C-8  (H-2 b,  Igha),  B10.A  (3R)  (K  b,  IA  b,  IB  b,  IJ  b,  IE  k,  IC  d, S  d,  Dd;  Ighb), and 
B10.A(5R) (K  b,  IA  b, IB  b, Iff, IE  k, IC  d, S  d, Dd; Igh  b) NP-primed mice. As shown 
in Table V, (B6 ×  C3H)F1-Ts3-1032  factor suppressed NP responses in C57BL/ 
6 mice and B10.A(3R) mice, but failed to suppress NP responses in B10.A(5R) 
and Igh congenic B.C-8  recipients. Thus,  the suppressive  activity mediated by 
(B6 ×  C3H)FI-Ts~-1032-derived factor is restricted by I-J and Igh-linked genes. 
hnmunochemical Characterization  of(B6 X  C3H)FFTs3-derived Factors 
The results of previous experiments demonstrated that TsF3 factors derived 
from C57BL/6 (H-2 b, Igh  b) donors reacted with anti-I-J  b and anti-NP  b antisera 
(7). Furthermore, additional indirect evidence predicted that C3H-derived TsF3 
would react with anti-I-J  k and anti-NP  j antisera (7,  12).  Thus, it is important to 
determine which I-J and Igh allelic products are expressed on the (B6 ×  C3H)F1 
derived TsF~ and to determine whether these determinants correlate with the 
genetic restrictions of the factors. Therefore, three of the factors were passed 
over a series of immunoadsorbent columns. As shown in Table VI, the suppres- 
sive activity of (B6 ×  C3H)F~-Ts3-1032  factor which was restricted to C57BL/6 
(Igh  b)  could be  depleted by passage  over anti-NP  b but not anti-NP  j  columns. 
Furthermore, the suppressive activity could be specifically recovered following 
acid elution. In contrast, the suppressive activity of (B6 ×  C3H)Ft-Ts~-I 131 and 
(B6 ×  C3H)FI-Ts3-1127-derived factors which suppressed NP-responses in C3H 
mice  (IghJ)  or  C3H.SW  (IghJ)  mice,  respectively,  were  adsorbed  by  anti-NP  j 
columns but not by anti-NP  b immunoadsorbent columns. 
In another series of experiments these factors were passed over several anti-I- 
J  columns. The suppressive activity of the control C57BL/6-derived B6-Ts~-2 
factor  could  be  depleted  by  passage  over  a  monocionai  anti-I-J  b (WF9-40.5) 
column or columns made by coupling conventional anti-I-J  b alloantiserum (anti- 
I-J  b) and the activity could be recovered by acid elution (Table VII). In contrast, 
the suppressive activity of a control CKB-derived CKB-Ts~-9 factor was adsorbed 
by two different batches of monoclonal anti-I-J  k (WF8.C2.4 and WF8.D2.4) or 
TABLE VI 
Fractionation of  Hybridoma-derived Suppressor Factors on Antiidiotype 
Columns* 
Antiidiotype  Fraction  F~-Tss-10320 FI-Ts~-1127  Fi-Ts3-1131  column 
None  Unfractionated  54 + 11"  64 + 9*  55 -  6* 
Anti-NP  b  Eluate  58 + 6*  9 -+ 8  -17 _+ 11 
Filtrate  0:1:3  60 + 9*  63 + 6* 
Anti-NP  j  Eluate  -4 + 6  51 _+ 7*  52 __. 8* 
Filtrate  35 __+ 9*  4 + 13  -8 _ 8 
*  C57BL/6, C3H.SW or C3H mice were used as recipients of(B6 × C3H)F~-Tsr 
1032,  (B6 ×  C3H)F~-Tss-1127 or (B6 X C3H)FI-Tss-I  131 factor, respectively. 
The mice were primed with NP-O-Su. On the day before and the day of  antigen 
challenge, 0.5 ml of the designated column fractions were injected i.v. 
t The data represent the pooled and normalized percent suppression from two 
or three separate experiments for each factor. An asterisk indicates significant 
suppression, P<0.01. MINAMI  ET  AL. 
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Fractionation of Hybridoma-derived Factors on Anti-I-J Immunoadsorbent Columns* 
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Anti-I-J  Fraction  B6-Ts3-2 CKB-Tss-9  Fi-Tss-1032  FrTss-l127  F1-Ts3-1131  column 
None  Unfractionated  44 _ 9*  41 + 8*  81 + 3*  74 ± 4*  42 ± 6* 
WF8.C2.4  Eluate  5 -  12  53 ±  10"  -2 ± 9  5 ± 9  56 ± 2* 
Filtrate  32 ± 6*  8 ± 6  43 ± 9*  76 ± 5*  2 ± 2 
WF8.D2.3  Eluate  3 ± 7  48 ± 9*  2 ± 5  0 ± 5  35 ± 3* 
Filtrate  55 ± 8*  5 ±  10  65 ± 8*  73 ± 6*  -5 _  11 
WF9.40.5  Eluate  49 ± 2*  10 ± 3  58 ± 3*  85 ± 3*  1 ±  10 
Filtrate  -7 ± 8  46 ± 7*  0 ± 4  1 ± 4  45 ± 3* 
Anti-I-J b  Eluate  33 ± 5*  5 +  13  65 ± 4*  74 ± 5*  -1 ± 2 
Filtrate  -12±3  49±5*  1±4  4±6  62±11" 
Anti-I-J k  Eluate  -3 ± 3  50 ± 6*  4 ± 5  0 ± 5  46 ± 9* 
Filtrate  56 ± 4*  12 ± 9  60 ± 8*  80 ± 3*  3 ± 9 
* Groups of mice were primed with NP-O-Su. On the day before and the day of antigen challenge, 
0.5 ml of the designated  column fractions were injected  i.v. C57BL/6 mice were recipients  of B6- 
Ts3-2 and (B6  ×  C3H)FI-Tss-1032  factor,  B10.BR  mice  were  recipients  of CKB-Tss-9 factor, 
C3H.SW recipients  were given (B6 ×  C3H)FI-Ts3-1127  factor and C3H mice were given  (B6 × 
C3H)FrTs3-1131 factor. 
0 The data represent  the pooled and normalized percent suppression  from one to three separate 
experiments for each factor. An asterisk indicates significant suppression, P<0.01. 
conventional anti-I-J  k columns. Three  (B6 ×  C3H)Fl-Tss-derived  factors, (B6 × 
C3H)F1-Ts3-1032,  (B6  ×  C3H)F1-Tss-1127,  and (B6  ×  C3H)FI-TS3-1131,  were 
passed over the same columns and the activity of the filtrate and eluate fractions 
were  tested  using  C57BL/6,  C3H.SW,  and  C3H  mice,  respectively.  The  sup- 
pressive activities of (B6 ×  C3H)FI-TS3-1032 and (B6 ×  C3H)F~-Ts3-1127 factors 
were  absorbed  by  monoclonal  anti-I-J  b  (WF9-40.5)  and  conventional  anti-I-J  b 
columns.  In contrast,  the suppressive activity of (B6  ×  C3H)F~-Tsa-1131  factor 
was adsorbed by monoclonal and conventional anti-I-J  k immunoadsorbents  (Ta- 
ble  VII).  The  I-J  and  Igh-related  determinants  on  (B6  ×  C3H)F1-Ts3-1114 
derived factor were not analyzed. 
Thus,  (B6  ×  C3H)FI-Ts3-1032  factor,  which  suppressed  NP-responses  in 
C57BL/6  (H-2b,Ighb)  recipients,  bears  I-J  b and  Npb-related  idiotypic  determi- 
nants.  Similarly,  (B6  ×  C3H)F~-Ts3-1127  factor,  which  is  specific for C3H.SW 
(H-2 b,  Igh  j)  recipients,  bears  I-J  b and  NPLrelated  idiotypic  determinants.  TsF3 
derived  from  (B6  ×  C3H)FI-TS3-1131  hybridoma  cells  carries  I-J  k  and  NPL 
related determinants  and its activity is restricted  to mice carrying the H-2  k and 
Igh  j haplotypes. 
Discussion 
We  had  previously  demonstrated  that  two  distinct  populations  of Ts3  cells, 
each  restricted  to one  parental  H-2  haplotype,  existed  in  H-2  heterozygous  F~ 
mice (12).  However, those previous studies  never evaluated  the Igh restrictions 
of the Ts3 cells from Igh heterozygous donors. The present studies focus on this 
issue. Two independent approaches were used.  First, heterogeneous populations 
of Ts3  cells  were  induced  in  (B6  ×  C3H)F~  donors and  activated  in  vitro  with 
monoclonal  TsF2.  The  activated  Ts3  cells  were  adoptively  transferred  to  Ts3- 1438  FUNCTIONAL  ALLELIC  EXCLUSION  IN  T  CELLS 
depleted C57BL/6, C3H.SW, C3H, or CKB recipients. Strict genetic restrictions 
controlled the activation of the F~-derived Ts3 populations. Thus, H-2 and Igh 
homology was always required  between  the TsFz  used for activation  and  the 
recipient strain (Table I). Thus, it appeared that four distinct Ts3 subpopulations, 
each with a  distinct combination of restriction specificities, existed within H-2 
and  Igh  heterozygous  F~  animals.  Although  these  conclusions  describe  the 
phenomena, they do not unravel the underlying mechanism responsible for the 
restrictions. One hypothesis to explain these restrictions is based on the previous 
demonstration  that  specialized  populations  of I-J-bearing  antigen  (or  factor)- 
presenting cells are required for imposing I-J genetic restrictions on suppressor 
T  cells  (8,  9).  Thus,  to  account  for  the  restrictions  between  TsF2  and  the 
recipients,  we  postulate  that  an  I-J-bearing  acceptor  cell  population  is  also 
involved in  the presentation  of TsF2.  Such cells could serve  to juxtapose  the 
TsF2 with  the Ts3  cells,  thereby  permitting the interactions required  for  Ts~ 
activation.  Furthermore,  since  suppressor  cell  interactions  can  occur  in  the 
absence of an external source of antigen (13, 25), the Igh restriction may reflect 
an antiidiotypic internal image (which substitutes for antigen). This hypothesis 
further suggests that such a system of internal images is in some fashion controlled 
by genes linked to the Igh complex. This speculative hypothesis, which attempts 
to account for the I-J and Igh restrictions, will require additional experimental 
support. 
The second approach to analyzing Ts3 specificity involved the hybridization 
of (B6 ×  C3H)Fa-derived Ts3 cells with the BW5147  thymoma. This approach 
led to the production of four monoclonal hybridoma cell lines. The hybridomas 
constitutively secreted soluble factors (TsF3) that mediated NP-specific effector 
phase suppressor activity (Tables II and III). The evidence that these hybridomas 
represented  Ts3  cells  included these  facts:  (a)  the  methods of induction  and 
enrichment were  based  on  those  used to identify the  Tss  population, (b)  the 
hybridomas  had  I-J  and  NP b  phenotypes  characteristic  of Ts3  cells,  (c)  the 
hybridoma cells produced NP-specific soluble suppressor factors that only func- 
tioned in the effector phase of the immune response in an  H-2  (I-J),  and Igh- 
restricted  fashion,  (d)  the  factors  were  active  in  cyclosphosphamide  treated 
recipients (data  not  shown), and (e) the  factors  specifically bound to  columns 
containing  allele-specific  anti-I-J  and  antiidiotypic  antibodies.  All  the  above 
features  are  characteristic  of Ts3  cells  and  their  factors  and  permit  one  to 
distinguish  Ts3  cells  from  the  other  suppressor  cells  and  factors  of the  NP 
suppressor cell cascade. 
The production of these  (B6  x  C3H)F~-derived  Ts3  hybridomas permitted 
analysis of the genetic restrictions  at the clonal level.  In conformation of the 
adoptive transfer data (Table I), we noted that each hybridoma was restricted to 
one of the parental H-2 and Igb haplotypes. Of the four hybridomas character- 
ized, we noted three distinct restriction specificities, including one clone, (B6 × 
C3H)F~-Ts3-1131,  which was restricted by H-2 k- and  IghLlinked genes (Table 
IV). The corresponding subpopulation in primed lymph node cells could not be 
identified using the adoptive transfer protocol, since C3H-derived TsF2 was not 
available.  Factors derived  from (B6  x  C3H)FI-Ts3-1127  cells specifically sup- 
pressed NP responses in C3H.SW (H-2b;  Igh  j) recipients (Table IV). Thus, the MINAMI  ET  AL.  1439 
latter F~ hybridoma clone demonstrated a "scrambled" restriction specificity, ie., 
the H-2 b restriction specificity was derived from the C57BL/6  parent and the 
IghJ restriction  specificity was derived from the C3H  parent.  Additional data 
supporting the notion of "scrambled" restriction specificities was obtained from 
the adoptive transfer  experiments in which in vitro-activated  (B6  ×  C3H)F1- 
derived Ts~ subpopulations specific for C3H.SW  (H-2b;  IghJ) and CKB (H-2k; 
Igh  b)  recipients  were  identified.  The  above  results  imply that  the  scrambled 
genetic restrictions may be a  consequence of a  receptor or an acceptor on the 
Ts3 population that recognizes a combined Igh and MHC specificity present in 
the Fl  recipients, and/or that the Igh and H-2 receptors responsible for these 
scrambled genetic restrictions are separately encoded in the genome and dem- 
onstrate independent assortment in Fl cells. 
Another important purpose of these studies was to evaluate any correlations 
between the I-J and idiotype-related determinants present on the Fa-derived Tss 
hybridoma cells and their  factors.  The level of complement-mediated lysis  of 
these and other hybridoma cells using specific anti-I-J alioantisera, was variable 
(27, 28). Although there have been claims that this variability was dependent on 
the cell cycle (29), little is known about such parameters.  Our initial screening 
suggested that all four F~-derived hybridoma cell lines reacted with both anti-I- 
jb and anti-I-J k alloantisera. Previous studies have also indicated that both parental 
I-J  alleles  are  expressed  on  H-2  heterozygous Fl-derived  T  cells  (12,  30).  In 
contrast,  the monoclonal suppressor factors derived from these F1 hybridoma 
cells reacted with only one set of allele-specific anti-I-J  reagents.  Both conven- 
tional  alloantisera  and  monoclonal anti-I-J  reagents,  specific  for  I-J  b and  I-J k 
allelic products, were used to examine the Frderived factors (Table VII). Either 
one of the TsF3 products secreted from each of the hybridomas was nonfunctional 
or the molecules derived from F1 hybridomas only carry one set of I-J determi- 
nants even though both I-J allelic products may be expressed on the cell surface. 
Data in another system also suggest that H-2 heterozygous Fl cells may produce 
TsF with only one parental I-J determinant (21), however, the phenotype of the 
Ts cells in those experiments was not determined. 
The correlation between the phenotypic expression of Igh-controlled idiotype- 
related  determinants of the  Frderived  cells and  factors  was  more  consistent. 
Thus, the (B6 ×  C3H)F1-Ts3-1032  cells were lysed with anti-NP b, but not anti- 
NP  j reagents, while the (B6 × C3H)FrTsrl 132 cells demonstrated the reciprocal 
pattern.  Furthermore,  the  TsF3  derived  from  these  hybridomas  specifically 
bound to immunoadsorbent columns containing the appropriate allele-specific 
antiidiotypic reagents. Cells from one hybridoma, (B6 ×  C3H)F1-Ts3-1127 were 
not lysed by either antiidiotypic reagent, but TsF~ derived from these cells was 
specifically bound by an anti-NP  j immunoadsorbent column. This finding sug- 
gested that the sensitivity of the column adsorptions was greater than that of the 
complement-mediated cytotoxicity tests.  Nonetheless, the fact that the antiidi- 
otypic reagents  could be  used  to  distinguish among the  hybridoma cells and 
factors suggests that the idiotype-like determinants detected by these reagents 
are allelically excluded on F~-derived Ts~ cells and factors. In contrast, there is 
codominant expression of I-J determinants on the Fl-derived hybridoma cells, 
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TsFa. It is interesting that Fl-derived TsF3 displays many of the same features of 
allelic exclusion as exhibited by immunoglobulins. Thus,  in  F~-derived B cells 
only one heavy chain and one light chain gene product is expressed (31).  There 
have, however, been several examples of aborted heavy or light chain rearrange- 
ments that affect the other parental chromosome (32, 33). Although the latter 
gene products are generally not secreted, in selected instances, they are produced 
and can be detected in nonsecreted form (34). 
A  complete correlation was found between the determinants on  F~-derived 
TsF3 and the restriction specificity of these factors. Thus, among the three Fl 
hybridoma-derived factors examined, those that were restricted to H-2  b, reacted 
with anti-I-J  b immunoadsorbent columns, whereas those restricted to H-2 k were 
bound by anti-I-J  k columns. Furthermore, when the activity of F~-derived TsF3 
was restricted to strains bearing Ighb-linked genes, the factors were bound by 
anti-NP  b columns but not immunoadsorbent columns specific for anti-NP anti- 
bodies derived from mice carrying the IghJ haplotype. The latter antiidiotypic 
reagents were capable of specifically binding (B6  x  C3H)F1-derived TsF3,  the 
activity of which  was  restricted to  strains  bearing  the  IghJ  haplotype.  These 
findings appear to conflict with the observations of Yamauchi et al. (35),  who 
reported  that  the  Igh  restriction  specificity of spleen  cell-derived  TsF  was 
controlled by the I-J-bearing chain. Although the factor described Yamauchi et 
al. is also a  two-chain heterodimer, it was derived from Lyt-l+ inducer Ts.  In 
contrast, the products described in the present report are derived from Lyt-2  + 
effector Ts; consequently direct comparisons of the present data with those of 
Yamauchi and colleagues may not be valid. 
Some recent reports have indicated that the I-J region may not code for a gene 
product (36).  These findings raise many questions as to the nature of the I-J 
products detected on T  cells by this and many other laboratories (1-4,  16-18). 
In fact, what has been shown in all these reports is that antibodies produced in 
3R-5R combinations can bind to suppressor cells and factors. We have recently 
examined this issue and concluded that the I-J determinants found on antigen- 
presenting  cells  (perhaps  a  modified  I-EB gene  product)  may  represent  the 
restricting elements (8,  9).  We  postulated  that  the determinants detected on 
suppressor T  cells and factors are anti-self I-J receptors that are recognized by 
antiidiotypic antibodies contaminating the conventional anti-I-J alloantisera (9). 
The monoclonai reagents used in this and other reports may also represent anti- 
receptor antibodies. In the current experiments, the restriction of TsF3 to the I- 
J  subregion  matching the  "I-J phenotype" of the factor may be attributed  to 
recognition of I-J products present in the recipient by clonally restricted anti-self 
I-J receptors on TsFa. Since the NP-specific TsF3 molecule consists of a disulfide- 
linked heterodimer, containing an antigen-binding chain and a second chain that 
reacts with anti-I-J antisera (11,  17),  it is tempting to create a model of TsFs in 
which each chain controls a  distinct restriction specificity, i.e.  a  two-receptor 
molecule. 
Finally,  it  is  important  to  evaluate  the  specificity of suppression  in  F~  vs. 
parental recipients. In the various experiments performed using either the Tsa 
cell  transfer protocol  or  the  analysis  of Fl-derived  TsFa,  we  noted  that  the 
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recipients.  If TsF3  is  specific for the  receptors on  CS effector cells we would 
expect a  lower degree of suppression on the CS responses in H-2 heterozygous 
F~ animals.  Therefore,  we must either entertain  the possibility that  the targets 
of Tsa cells or TsF~ are not the CS effector population (2,  37, 38) and/or that 
the final suppressor mechanism may demonstrate bystander suppression (39, 40). 
Summary 
In  the  4-hydroxy-3-nitrophenyl  acetyi  (NP)  contact  sensitivity  system,  the 
activity of third-order  suppressor cells and their factors is restricted by H-2(I-J) 
and Igh linked genes. The present report analyzes the specificity of NP-specific 
Tss  cells and  factors derived  from  H-2  and  Igh  heterozygous (B6  ×  C3H)F1 
mice.  Two approaches  were used.  First,  heterogeneous populations  of FI  Tss 
cells were activated in  vitro and  then  assayed in  Tss-depleted recipients which 
carried different combinations of H-2 and Igh alleles. The second approach was 
to hybridize the Ts3 cells and analyze the specificity of the Fl-derived TsF3. The 
combined data demonstrated four functionally distinct populations of Ts3 cells. 
The activity of each population was restricted by a particular combination of H- 
2 and Igh haplotypes. Thus, Ts3 cells derived from F1 donors can demonstrate 
an apparent scrambling of H-2 and Igh restriction specificities. 
There  was functional  allelic exclusion of the  H-2(I-J) and  Igh  determinants 
expressed on  (B6  ×  C3H)F~  hybridoma-derived  TsF~.  Thus,  TsF3  from each 
cloned  hybridoma  line  expressed  only  one  set  of I-J  and  Igh  determinants. 
Furthermore,  there was a  complete correlation between the I-J and Igh linked 
determinants expressed on TsF~ and the restriction specificity. 
In view of the recent findings on the molecular biology of the I-J region, an 
alternative interpretation  of the role of I-J determinants on suppressor cells and 
factors is offered. 
The authors express their appreciation to Mrs. N. Axelrod and M. J. Tawa for expert 
secretarial  assistance and to Dr. D. H. Sherr for helpful discussions. 
Received for publication 18 April 1983. 
References 
1.  Germain, R. N., and B. Benacerraf.  1981. A single major pathway of T-lymphocyte 
interactions  in antigen-specific  immune suppression. Scand. J. Immunol.  13:1. 
2.  Flood,  P.,  K.  Yamauchi,  and  R.  K.  Gershon.  1982.  Analysis of the  interactions 
between two molecules that are required for the expression  of Ly-2 suppressor cell 
activity.  Three  different  types of focusing events may be needed  to deliver  the 
suppressive signal.J.  Exp. Med.  156:361. 
3.  Kapp, J. A., and B. A. Araneo. 1982. Antigen-specific suppressor T cell interactions. 
I. Induction of an MHC-restricted suppressor factor specific for L-glutamic acid~°-L  - 
tyrosineS°.J.  Immunol.  128:2447. 
4.  Claman,  H. N., S. D. Miller,  P. J. Conlon, and J. w. Moorhead.  1980. Control of 
experimental contact sensitivity. Adv. Immunol.  30:121. 
5.  Weinberger, J. Z., R. N. Germain,  B. Benacerraf, and  M. E.  Dorf.  1980.  Hapten- 
specific T-cell  responses  to 4-hydroxy-3-nitrophenyl  acetyl.  V.  Role of idiotypes  in 
the suppressor pathway. J. Exp. Med.  152:161. 1442  FUNCTIONAL ALLELIC  EXCLUSION  IN  T  CELLS 
6.  Sunday, M. E., B. Benacerraf, and M. E. Dorf. 1981. Hapten specific T  cell responses 
to 4-hydroxy-3-nitrophenyl acetyl. VIII. Suppressor cell pathways in cutaneous sen- 
sitivity responses.J. Exp. Med. 153:811. 
7.  Okuda,  K.,  M.  Minami,  S.  Furusawa,  and  M.  E.  Dorf.  1981.  Analysis of T  cell 
hybridomas. II. Comparisons among three distinct types of monoclonal suppressor 
factors.J. Exp. Med. 154:1838. 
8.  Minami,  M.,  N.  Honji, and M.  E.  Dorf.  1982.  The mechanism responsible for the 
induction of I-J restrictions on Ts3 suppressor cells. J. Exp. Med. 156:1502. 
9.  Aoki,  I.,  M.  Minami,  and  M.  E.  Dorf.  1983.  A  mechanism  responsible  for  the 
induction of H-2 restricted second-order suppressor T  cells. J. Exp. Med. 157:1726. 
10.  Sherr, D. H., and M. E. Dorf.  1981.  Hapten-specific T  cell responses to 4-hydroxy- 
3-nitrophenyl acetyl. IX. Characterization of idiotype-specific effector phase suppres- 
sor cells on pique-forming cell responses in vitro.J. Exp. Med. 153:1445. 
11.  Sherr,  D.  H.,  M.  Minami,  K.  Okuda,  and  M.  E.  Dorf.  1983.  Analysis of T  cell 
hybridomas. III. Distinctions between two types of hapten-specific suppressor factors 
which affect plaque-forming cell responses. J. Exp. Med. 157:515. 
12.  Minami, M., S. Furusawa, and M. E. Dorf. 1982. I-J restrictions on the activation and 
interaction of parental and Fi derived Ts3 suppressor cells. J. Exp. Med. 156:456. 
13.  Minami,  M.,  K.  Okuda,  S.  Furusawa,  and  M.  E.  Dorf.  1983.  Analysis of T  cell 
hybridomas.  IV.  Characterization  of inducible  suppressor cell hybridomas. J.  Exp. 
Med. 157:1379. 
14.  Sherr, D. H., and M.  E. Dorf.  1982.  Hapten specific T  cell responses to 4-hydroxy- 
3-nitrophenyl acetyl. XIII. Characterization of a third order T  cell (Ts3) involved in 
suppression of in vitro PFC responses. J. Immunol. 128:1261. 
15.  Taniguchi, M., I. Takei, and T. Tada.  1980. Functional and molecular organisation 
of an antigen-specific suppressor factor from a  T  cell  hybridoma. Nature  (Lond.). 
283:227. 
16.  Taniguchi,  M.,  T.  Saito, I. Takei, and T.  Tokuhisa.  1981.  Presence of interchain 
disulfide bonds between two gene products that compose the secreted form of an 
antigen-specific suppressor factor. J. Exp. Med. 153:1672. 
17.  Furusawa,  S.,  M.  Minami,  D.  H.  Sherr,  and  M.  E.  Dorf.  1983.  Analysis  of the 
suppressor T  cell  cascade with  products derived from T  cell hybridomas. In  Cell 
Fusion.  R.  F.  Beers, Jr.  and  E.  G.  Basset,  editors.  Raven  Press,  New  York.  pp. 
299-313. 
18.  Lei,  H., S.  T. Ju,  M.  E.  Dorf, and C. Waltenbaugh.  1983.  Regulation of immune 
responses by  I-J gene products.  III. GT-specific suppressor factor is composed of 
separate I-J and idiotype bearing chains. J. lmmunol.  130:1274. 
19.  Okuda,  K.,  M.  Minami,  S.  T. Ju, and  M.  E.  Dorf.  1981.  Functional  association of 
idiotypic and  I-J determinants on the antigen  receptor of suppressor T  cells.  Proc. 
Natl. Acad. Sci. USA. 78:4557. 
20.  Waltenbaugh,  C.  1981.  Regulation  of immune responses by I-J gene  products.  I. 
Production  and  characterization  of anti-I-J  monoclonal  antibodies. J.  Exp.  Med. 
154:1570. 
21.  Lei, H. Y., M. E. Dorf, and C. Wahenbaugh.  1982. Regulation of immune responses 
of I-J gene products. II. Presence of both I-J  b and I-J  k suppressor factors in (nonsup- 
pressor × nonsuppressor)Fl mice.J. Exp. Med. 155:955. 
22.  Ju,  S.,  B.  Benacerraf,  and  M.  E.  Dorf.  1978.  Idiotypic analysis  of antibodies  to 
poly(Glu6°Ala3°Tyr  J°): interstrain and interspecies idiotypic cross-reactions. Proc. Natl. 
Acad. Sci. USA. 75:6192. 
23.  Ju, S., and M. E. Dorf. 1981. Cross-induction of predominant NP  b idiotypic antibodies 
with derivatives of (4-hydroxy-3-nitrophenyl) acetyl.J. Immunol.  127:2224. MINAM1 ET  AL.  1443 
24.  Minami, M., K. Okuda, S. Furusawa, B. Benacerraf, and M. E. Dorf. 1981. Analysis 
of T  cell  hybridomas.  I.  Characterization  of H-2  and  Igh  restricted  monoclonai 
suppressor factors. J. Exp. Med. 154:1390. 
25.  Okuda, K., M. Minami, D.  H. Sherr, and M. E. Dorf.  1981. Hapten-specific T  cell 
responses to 4-hydroxy-3-nitrophenyl  acetyl. XI. Pseudogenetic restrictions of hybri- 
doma suppressor factors.J. Exp. Med. 154:468. 
26.  Sunday,  M.  E., J.  Z.  Weinberger,  B.  Benacerraf, and  M.  E.  Dorf.  1980.  Hapten- 
specific T  cell responses to 4-hydroxy-3-nitrophenyl acetyl. IV. Specificity of cuta- 
neous sensitivity responses. J. lmmunoL 125:1601. 
27.  Dorf, M. E., K. Okuda, and M. Minami. 1982. Dissection of a suppressor cell cascade. 
Curt. Top. Microbiol. hnmunol.  100:61. 
28.  Trial, J., J.  A.  Kapp,  C.  W.  Pierce,  D.  C.  Shreffier,  C.  M.  Sorensen,  and  C. 
Waltenbaugh.  1983. Expression of cell surface antigens by suppressor T  cell hybri- 
domas. I. Comparison of phenotype and function. J. Immunol.  130:565. 
29.  Kanno,  M.,  I. Takei,  N.  Suzuki,  H.  Tomioka, and  M.  Taniguchi.  1980.  Periodic 
expression of antigen-binding and I-J molecules on the Ts hybridoma. Proc.  Jpn. Soc. 
lmmunol.  10:41. 
30.  Okuda, K., C. S. David, and D. C. Shreffler. 1977. The role of gene products of the 
I-J subregion in mixed lymphocyte reactions. J. Exp. Med. 146:1561. 
31.  Pernis, B., G. Chiappino, A. S. Kelus, and P. G. H. Gell. 1965. Cellular localization 
of immunoglobulins with different aUotypic specificities in rabbit lymphoid tissues.J. 
Exp. Med. 122:853. 
32.  Perry, R. P., D. E. Kelley, C. Coleclough, J. G. Seidman, P. Leder, S. Tonegawa, G. 
Matthyssens, and  M.  Weigert,  1980.  Transcription of mouse kappa  chain genes: 
implications for allelic exclusion. Proc. Natl. Acad. Sci. USA. 77:1937. 
33.  Hieter, P. A., S.J. Korsmeyer, G. F. Hollis, E. E. Max,J. V. Maizei, T. A. Waldmann, 
and  P.  Leder.  1981.  Immunoglobulin  light  chain  genes  of mouse  and  man.  In 
Immunoglobulin  Idiotypes.  C.  Janeway,  E.  E.  Sercarz,  and  H.  Wigzell  editors. 
Academic Press, New York. p. 33. 
34.  Schwartz, R. C., G. E. Sonenshein, A. Bothwell, and M. L. Gefter. 1981. Multiple 
expression of Ig lambda-chain encoding RNA species in murine plasmacytoma cells. 
J. lmmunol.  126:2104. 
35.  Yamauchi,  K.,  N.  Chao,  D.  B.  Murphy,  and  R.  K.  Gershon.  1982.  Molecular 
composition of an antigen-specific, Ly-1  suppressor inducer factor. One molecule 
binds antigen and is I-J-; another is I-J  +, does not bind antigen, and imparts an Igh- 
variable region linked restriction.J. Exp. Med. 155:655. 
36.  Steinmetz, M., K. Minard, S. Horvath,J. McNicholas,J. Srelinger, C. Wake, E. Long, 
B. Mach, and L. Hood. 1982. A. molecular map of the immune response region from 
the major histocompatibility complex of the mouse. Nature (Lond.). 300:35. 
37.  Ptak, W., M. Zembala, and R. K. Gershon. 1978. Intermediary role of macrophages 
in the passage of suppressor signals between T-cell subsets. J. Exp. Med. 148:424. 
38.  Asherson, G. L., and M. Zembala. 1982. The role of the T acceptor cell in suppressor 
systems: antigen-specific T  suppressor factor acts via a T  acceptor ceil: this releases a 
non-specific inhibitor of the transfer of contact sensitivity when exposed to antigen 
in the context of I-J. Ann. N. Y. Acad. Sci. 392:71. 
39.  Taniguchi, M., and T. Tokuhisa.  1980. Cellular consequences in the suppression of 
antibody response by the antigen-specific T cell factor.J. Exp. Med. 151:517. 
40.  Fresno, M., L. Mcvay-Boudreau, and H. Cantor. 1982. Antigen-specific T lymphocyte 
clones. III. Papain splits purified T suppressor molecules into two functional domains. 
J. Exp. Med. 155:981. 